OpenAI Poised to Lead AI IPO Race with Confidential Filing Report Zscalers ZeroTrust Strategy Faces a Potential Turnaround Test Trump Asks Supreme Court to Delay Enforcement of TikTok Ban Nifty Metal Index Surges 18 YTD Adding 16 Lakh Crore in Investor Wealth as Broader Market Slips Princeton CorpGov Forum Debates Endowment 5 Spending Rule and LongTerm Investment Strategy Indian Market Breadth Weakness May Keep Nifty in Sideways Trend Banking and IT Sectors in Focus AgEagle Aerial Systems UAVS Q3 2023 Earnings Narrowed Loss Amid Strategic Pivot No Revenue Reported SXTP Q1 2026 Earnings Significant EPS Miss as Company Continues PreRevenue Phase Capital Bancorp Inc CBNK Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Decline LUXE Q1 2026 Earnings EPS Miss Weighs on Sentiment as Revenue Data Remains Withheld TSAT Q1 2026 Earnings Massive EPS Miss Overshadows Missing Revenue as Stock Edges Higher GSBC Q1 2026 Earnings Robust EPS Beat Drives Positive Market Reaction Nuveen Municipal Credit Income Fund NZF Holds Near Support Edges Higher on Cautious Bond Market Ermenegildo Zegna ZGN Stock Hovers Near Support Amid Modest Decline K2 Capital Acquisition KTWO Edges Higher in LowVolume Trading Near Support Levels Tennessee Valley Authority TVE Holds Steady Near Support as Yield Attracts Defensive Flows Liberty Media Formula One FWONA Edges Lower as Key Support Levels Come into Focus Jim Cramer Discusses ServiceNow NOW Amid Enterprise Software Growth Carvana CVNA Analysts Revise Price Targets Following Stock Split Japanese Snack Maker Behind Shiruko Sand Targets Singapore and Southeast Asia for Expansion Ralph Lauren Corporation Reports Q4 2026 Results Focus on Brand Momentum and Strategic Execution PostSummit Deals White House Highlights Soybean and Rare Earth Pacts China Emphasizes Tariff Reductions IBM Gains 27 Billion in Market Cap After US Quantum Computing Investment Announcement Cramers Market Commentary Highlights Potential Opportunities Amid Shifting Sector Dynamics CDNS Q1 2026 Earnings Earnings Beat Estimates Stock Rises CanFite Biopharma CANF Slips 32 as Stock Tests Key Support Level